4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Penumbra, Inc. (PEN) operates in the Medical Devices industry and is headquartered in Alameda, United States with about 4,700 employees. Its market capitalization is roughly $13 billion. In the fiscal year ended 2025-12-31, PEN reported $1.4B in revenue and $178M in net income.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally.
Interactive charts & full statements → Open the PEN valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $1.4B | $1.2B | $1.1B | $847M | — |
| Gross Profit | $942M | $755M | $683M | $535M | — |
| Operating Income (EBIT) | $189M | $86M | $92M | $6M | — |
| Net Income | $178M | $14M | $91M | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $375M | $385M | $355M | $340M | $324M | — |
| Gross Profit | $253M | $262M | $240M | $224M | $216M | — |
| Operating Income (EBIT) | $38M | $59M | $49M | $41M | $40M | — |
| Net Income | $33M | $47M | $46M | $45M | $39M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.8B | $1.5B | $1.6B | $1.4B | — |
| Total Liabilities | $399M | $382M | $377M | $372M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PEN viewer.
About TickerBase · Data methodology & sources